On February 3, 2022 Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)- based DNA manufacturing and nucleic acid-based technologies, reported that it will report fiscal 2022 first quarter financial results after market close on Thursday, February 10, 2022 (Press release, Applied DNA Sciences, FEB 3, 2022, View Source;id=222885&p=2218540&I=1206939-c7Z3G6f3m8 [SID1234607707]). The Company’s management will discuss the results during a conference call and simultaneous webcast at 4:30 p.m. ET that same day. Presentation slides will also be posted to the ‘Company Events’ sub-page of the Company’s Investor Relations website and embedded into the live webcast.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Conference Call and Webcast Information – Live
Date:
Thursday, February 10, 2022, at 4:30 p.m. Eastern Time
Dial in:
844-887-9402
412-317-6798 (international)
Hosts:
Dr. James A. Hayward, chairman, president, and CEO
Beth Jantzen, chief financial officer
Webcast:
Conference Call and Webcast Information – Replay
A telephonic replay of the conference call will be available for one week beginning one hour after the end of the live conference call.
Dial in:
877-344-7529
412-317-0088 (international)
Access Code: 2723913
Webcast:
Availability:
Telephonic replay: until Thursday, February 17, 2022; webcast replay: 1 year